Death of TB Champion, Rep. Donald Payne

Payne — U.S. Representative Donald Payne (D-NJ)

TB R&D Weekly Update: Podcast Interview with Dr. Tawanda Gumbo

Tawanda_Gumbo.27720418_std — Dr. Tawanda Gumbo

TB R&D Weekly Update: CSU Identifies Anti-TB Compound against Unique Target

Grzegorzewicz AE, Pham H, Gundi VA, Scherman MS, North EJ, Hess T, Jones V, Gruppo V, Born SE, Korduláková J, Chavadi SS, Morisseau C, Lenaerts AJ, Lee RE, McNeil MR, Jackson M.

Innovative Professional Development Resource for Clinical Researchers and More

globalhealthtrials — Click here

TB R&D Weekly Update: Tailoring TB Treatment Based on Host Genotype?

Tobin DM, Roca FJ, Oh SF, McFarland R, Vickery TW, Ray JP, Ko DC, Zou Y, Bang ND, Chau TT, Vary JC, Hawn TR, Dunstan SJ, Farrar JJ, Thwaites GE, King M, Serhan CN, Ramakrishnan L.

News from the 21st Stop TB Partnership Coordinating Board Meeting, Bangkok

Summary Available! TB Clinical Trials Consultants Meeting

On November 17 and 18, a TB Clinical Trials Consultants Meeting was held at St. George’s, University of London.

TB R&D Weekly Update: SQ109 and PNU Compounds Additive

Reddy VM, Dubuisson T, Einck L, Wallis RS, Jakubiec W, Ladukto L, Campbell S, Nacy CA. SQ109 and PNU-100480 interact to kill Mycobacterium tuberculosis in vitro. J Antimicrob Chemother. 2012 Jan 17. [Epub ahead of print]

TB R&D Weekly Update: TDR Tuberculosis Strain Bank

Kick TB Campaign: Scoring Big in South Africa and Beyond

The Kick TB Campaign is a unique project that uses the World’s most popular sport to educate and engage young people in the effort to stop the spread of tuberculosis (TB). The campaign began in 2009 in South Africa and has been so successful that other countries in Africa and Asia are taking interest.

Pages

©2016 Working Group on New TB Drugs. All Rights Reserved. Terms of Reference Site by Darby Communications